All News Nkarta, Inc.

Equities

NKTX

US65487U1088

Real-time Estimate Cboe BZX Other stock markets 17:48:30 13/05/2024 BST			5-day change	1st Jan Change
6.48 ^USD	+3.68%		-8.59%	-1.67%

05-09	Nkarta, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-26	Canaccord Genuity Adjusts Nkarta's Price Target to $16 From $15, Keeps Buy Rating	MT

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nkarta, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-09	CI
Nkarta Reports First Quarter 2024 Financial Results and Corporate Highlights	05-09	AQ
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Nkarta, Inc. (NKTX) on Behalf of Investors	04-08	BU
Law Offices of Howard G. Smith Announces Investigation of Nkarta, Inc. (NKTX) on Behalf of Investors	04-05	BU
The Law Offices of Frank R. Cruz Announces Investigation of Nkarta, Inc. (NKTX) on Behalf of Investors	04-05	BU
Nkarta to Participate in Upcoming Investor Conferences	04-03	AQ
Canaccord Genuity Adjusts Nkarta's Price Target to $16 From $15, Keeps Buy Rating	03-26	MT
HC Wainwright Adjusts Price Target on Nkarta to $22 From $20, Keeps Buy Rating	03-25	MT
Nkarta Prices $240.1 Million Underwritten Offering	03-25	MT
Nkarta Announces Pricing of $240 Million Underwritten Offering	03-25	AQ
North American Morning Briefing : Tech in Focus on -2-	03-25	DJ
Mizuho Securities Lowers Price Target on Nkarta to $25 From $31, Keeps Buy Rating	03-22	MT
Mizuho Securities Cuts Price Target on Nkarta to $25 From $31, Maintains Buy Rating	03-22	MT
HC Wainwright Adjusts Nkarta's Price Target to $20 From $22, Keeps Buy Rating	03-22	MT
Raymond James Downgrades Nkarta to Outperform From Strong Buy, Price Target is $16	03-22	MT
Nkarta Trims Q4 Loss -- Shares Up After Hours	03-21	MT
Nkarta Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights	03-21	AQ
Nkarta, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	03-21	CI
Mizuho Securities Adjusts Price Target on Nkarta to $31 From $9 as Lupus Nephritis Program Gets Attention, Keeps Buy Rating	03-04	MT
Nkarta to Participate in Upcoming Investor Conferences	02-28	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Nkarta, Inc.

Equities

NKTX

US65487U1088

All News

Filters